Abstract
Results of a study on the metabolic side-effects of depot-medroxyprogesterone acetate (DMPA) in undernourished lactating women, compared with non-lactating women, in three centres in India and Thailand are reported. Analysis of the data on anthropometric and biochemical parameters at the time of recruitment indicated that the lactating women were lighter and had lower plasma glucose and triglyceride levels and a higher alkaline phosphatase activity. Serum cholesterol levels tended to be higher during the first six months of lactation. Use of DMPA over a period of one year was not associated with any alteration in glucose tolerance and in the serum triglyceride, total protein and albumin levels. The observed fall in the cholesterol level and alkaline phosphatase activity in DMPA users might be attributed to waning lactation.
Full text
PDF







Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Amatayakul K., Sivassomboon B., Singkamani R. Effects of medroxyprogesterone acetate on serum lipids, protein, glucose tolerance and liver function in Thai women. Contraception. 1980 Mar;21(3):283–297. doi: 10.1016/0010-7824(80)90007-4. [DOI] [PubMed] [Google Scholar]
- Amatayakul K. The effects of depo-provera on carbohydrate, lipids and vitamin metabolism. J Steroid Biochem. 1979 Jul;11(1B):475–481. doi: 10.1016/0022-4731(79)90070-0. [DOI] [PubMed] [Google Scholar]
- Beck P., Zimmerman D. E., Eaton R. P. Effect of contraceptive steroids on arginine-stimulated glucagon and insulin secretion in women. III. Medroxyprogesterone acetate. Metabolism. 1977 Nov;26(11):1193–1198. doi: 10.1016/0026-0495(77)90111-1. [DOI] [PubMed] [Google Scholar]
- Dhall K., Kumar M., Rastogi G. K., Devi P. K. Short-term effects of norethisterone oenanthate and medroxyprogesterone acetate on glucose, insulin, growth hormone, and lipids. Fertil Steril. 1977 Feb;28(2):156–158. doi: 10.1016/s0015-0282(16)42374-5. [DOI] [PubMed] [Google Scholar]
- Grossman R. A., Asawasena W., Chalpati S., Taewtong D., Tovanabutra S. Effects of the injectable contraceptive depot medroxyprogesterone acetate in Thai women with liver fluke infestation: final results. Bull World Health Organ. 1979;57(5):829–837. [PMC free article] [PubMed] [Google Scholar]
- Nash H. A. Depo Provera: a review. Contraception. 1975 Oct;12(4):377–393. doi: 10.1016/0010-7824(75)90074-8. [DOI] [PubMed] [Google Scholar]
- Prema K., Gayathri T. L., Ramalakshmi B. A., Madhavapeddi R., Philips F. S. Low dose injectable contraceptive norethisterone enanthate 20mg monthly--I. Clinical trials. Contraception. 1981 Jan;23(1):11–22. doi: 10.1016/0010-7824(81)90110-4. [DOI] [PubMed] [Google Scholar]
- Saleh F. M., Abd-el-Hay M. M. Liver function tests after the use of long-acting progestational contraceptives. Contraception. 1977 Oct;16(4):409–416. doi: 10.1016/0010-7824(77)90052-x. [DOI] [PubMed] [Google Scholar]
- Spellacy W. N., Mcleod A. G., Buhi W. C., Birk S. A. The effects of medroxyprogesterone acetate on carbohydrate metabolism: measurements of glucose, insulin, and growth hormone after twelve months' use. Fertil Steril. 1972 Apr;23(4):239–244. [PubMed] [Google Scholar]
- Tankeyoon M., Dusitsin N., Poshyachinda V., Larsson-Cohn U. A study of glucose tolerance, serum transaminase and lipids in women using depot-medroxyprogesterone acetate and a combination-type oral contraceptive. Contraception. 1976 Aug;14(2):199–214. doi: 10.1016/0010-7824(76)90088-3. [DOI] [PubMed] [Google Scholar]
- Tyler E. T., Levin M., Elliot J., Dolman H. Present status of injectable contraceptives: results of seven-years study. Fertil Steril. 1970 Jun;21(6):469–481. doi: 10.1016/s0015-0282(16)37562-8. [DOI] [PubMed] [Google Scholar]
- Vermeulen A., Thiery M. Hormonal contraceptives and carbohydrate tolerance. II. Influence of medroxyprogesterone acetate and chronic oral contraceptives. Diabetologia. 1974 Aug;10(4):253–259. doi: 10.1007/BF02627727. [DOI] [PubMed] [Google Scholar]
